Skip to main content

Table 2 Multivariate Cox analysis of factors associated with survival

From: The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study

Characteristics

OS

PFS

 

3-year (%)

Univariate

Multivariate

3-year (%)

Univariate

Multivariate

 

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

Extra-regional lymph nodes metastases

No

68.7

Reference

 

Reference

 

26.7

Reference

   

Yes

51.5

2.006 (1.704–3.748)

0.029

2.472 (1.247–4.903)

0.010

17.4

1.613 (0.994–2.617)

0.053

  

Clinical N stage

  

0.002

 

0.001

  

0.001

 

0.007

N0

83.6

Reference

 

Reference

 

31.9

Reference

 

Reference

 

N1

66.2

2.504 (1.164–5.387)

0.019

2.834 (1.256–6.396)

0.012

21.3

1.342 (0.888–2.028)

0.163

1.342 (0.888–2.028)

0.163

N2

48.3

4.195 (1.972–8.924)

<0.01

4.602 (2.055–10.305)

<0.01

17.4

2.083 (1.353–3.206)

0.001

2.100 (1.364–3.231)

0.001

Fibrinogen (G/L)

          

≤3.41

80.2

Reference

 

Reference

 

27.6

Reference

   

> 3.41

55.1

2.777 (1.593–4.840)

<0.01

2.254 (1.246–4.078)

0.007

24.9

1.008 (0.720–1.409)

0.965

  

Primary tumor resection

No

42.8

Reference

 

Reference

 

28.5

Reference

   

Yes

69.1

0.501 (0.261–0.960)

0.037

0.367 (0.148–0.908)

0.030

24.9

1.385 (0.798–2.404)

0.246

  

PLR

≤208.48

72.3

Reference

   

28.8

Reference

 

Reference

 

> 208.48

49.7

2.448 (1.448–4.028)

<0.01

2.396 (1.391–4.126)

0.002

13.4

1.414 (0.985–2.031)

0.061

1.371(0.953–1.972)

0.09

  1. Abbreviations: BMI body mass index; WBC white blood cell; LMR lymphocyte-to-monocyte ratio; NLR neutrophil-to-lymphocyte ratio; PLR platelet to-lymphocyte ratio; CA-199 carbohydrate antigen 19–9; CEA carcinoembryonic antigen; HR hazard ratio; CI confidence interval; PFS progression-free survival; OS overall survival